TrademarkDir
OMNIVANCE
LIVE

Serial Number

88338800

Owner

QPEX BIOPHARMA, INC.

Attorney

Gregory B. Phillips

First Use Date

Nov 3, 2020

Filing Date

Mar 13, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OMNIVANCE Trademark

Serial Number: 88338800 • Registration: 6273428

OMNIVANCE is a trademark filed by QPEX BIOPHARMA, INC. on March 13, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

QPEX BIOPHARMA, INC. (3 trademarks)

San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

March 13, 2019

Registration Date

February 16, 2021

First Use Anywhere

November 3, 2020

First Use in Commerce

November 3, 2020

Published for Opposition

October 15, 2019

Goods & Services

Research and development of pharmaceuticals and antimicrobials

Pharmaceutical preparations for the treatment and prevention of infections and infectious diseases; Antimicrobial preparations for the treatment and prevention of infections and infectious diseases

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 16, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 16, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 9, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 8, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 17, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 17, 2020 AITU
USE AMENDMENT FILED
Dec 7, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 7, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2020 EXRA
SOU EXTENSION 1 GRANTED
Jun 8, 2020 EX1G
SOU EXTENSION 1 FILED
Jun 8, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 8, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 10, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 30, 2019 GPRN
PRIORITY ACTION E-MAILED
May 30, 2019 GPRA
PRIORITY ACTION WRITTEN
May 30, 2019 CPRA
ASSIGNED TO EXAMINER
May 22, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2019 NWOS
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2019 CRFA
ASSIGNED TO LIE
Mar 28, 2019 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 22, 2019 PARI
NEW APPLICATION ENTERED
Mar 16, 2019 NWAP

Related Trademarks

More from this Owner

ORAVANCE

ORAVANCE

ORAVANCE

ORAVANCE

ORAVANCE

ORAVANCE

QPEX BIOPHARMA

QPEX BIOPHARMA

QPEX BIOPHARMA

QPEX BIOPHARMA

QPEX BIOPHARMA

QPEX BIOPHARMA